The Company's Emergency Use Authorization submission is for the new Co-Dx PCR Pro instrument and COVID-19 test kit, designed for point-of-care and at-home. The menu of tests in development for the platform includes TB, HPV, and a multiplex respiratory panel for flu A/B, COVID-19, and RSV
https://finance.yahoo.com/news/co-diagnostics-inc-completes-submission-143000607.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.